New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
11:04 EDTDGXQuest Diagnostics acquisition a strategic positive, says Maxim
Maxim views Quest Diagnostics' acquisition of Solstas Lab Partners as a strategic positive and it recommends buying the stock following the news. The firm reiterates a Buy rating on the stock with a $73 price target.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for DGX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use